All News

Found 3,291 articles

• PolyTherics Announces a Research Collaboration With Spirogen Ltd. to Develop Novel Antibody-Drug Conjugates for the Treatment of Cancer

  4/2/2012

• Celtic Therapeutics Pledges $50 Million to Establish ADC Therapeutics, New Company Will Develop Antibody-Drug Conjugates

  3/26/2012

• GI Dynamics Designates First EndoBarrier® Center of Excellence in Australia

  3/8/2012

• Mersana Therapeutics, Inc. Strikes $270 Million Antibody-drug Conjugate Deal With Endo Pharmaceuticals

  3/7/2012

• Intellect Neurosciences, Inc. Receives Notice of Allowance from United States Patent and Trademark Office for its ANTISENILIN(R) Alzheimer's Disease Immunotherapy Technology Platform

  3/6/2012

• Intellect Neurosciences, Inc. Submits Statement Setting Grounds for Appeal in European Patent Proceedings

  2/14/2012

• Intellect Neurosciences, Inc. Files New Patent Applications for Immunotherapy Methods to Target Abnormal Tau Protein in Treatment of Alzheimer's disease

  2/7/2012

• Intellect Neurosciences, Inc. Issues Letter to Shareholders

  2/3/2012

• Seattle Genetics, Inc. Lymphoma Drug Gets Boxed Warning on Brain Infection Risk

  1/18/2012

• Ventana Medical Systems, Inc. to Collaborate With Bayer Pharma S.A. on Companion Diagnostic Test for New Biological Cancer Therapy

  1/17/2012

• Intellect Neurosciences, Inc. to Present at Biotechnology Industry Organization (BIO) Asia International Conference

  1/17/2012

• Oxford BioTherapeutics Appoints C. Glenn Begley as a Senior Clinical Advisor and Non-executive Director

  1/11/2012

• ImmunoGen, Inc. Announces Antibody-Drug Conjugate Collaboration With Eli Lilly and Company Worth Up to $200 Million

  12/20/2011

• Salix Pharmaceuticals, Ltd. and Progenics Pharmaceuticals, Inc. Announce Positive Highly Statistically Significant Results of Oral Methylnaltrexone for Phase 3 Trial in Chronic, Non-Cancer Pain Subjects with Opioid-Induced Constipation

  12/20/2011

• PRANA Biotechnology Commences Alzheimer's Trial Recruitment

  12/15/2011

• Astellas Pharma Inc. Adds Two Key Senior Executives at Agensys, Inc.

  12/1/2011

• PRANA Biotechnology Receives Approval for Alzheimer's Trial

  11/22/2011

• Intellect Neurosciences, Inc. Announces Its New CONJUMAB-A Platform Technology for Novel Treatments of Alzheimer's Disease and Other Proteinopathies

  10/26/2011

• Neurosearch A/S to Axe Workforce by 82.5 Pct. in Next 2 Years

  9/29/2011

• La Merie Release: Antibody-Drug Conjugates 2011 - Real Breakthrough Still to Come

  9/19/2011